glp-1 weight loss drug news november 2025 Alarming rise in overdoses Americans turn to risky unregulated

Regarding fibrosis, while direct anti-fibrotic mechanisms are less established, preclinical studies indicate that GLP-1 RAs could suppress fibrogenic cell activation and reduce expression of pro-fibrotic genes encoding extracellular matrix proteins, potentially facilitating fibrosis regression in conjunction with improvements in steatosis and inflammation [29-32]

This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 4.0 License (CC BY-NC 4.0), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited

10.1111/j.1440-1681.2007.04737.x 87

During your consultation at our NYC weight loss center, our team will evaluate your health history, lifestyle, and goals to see if GLP-1 therapy is right for you

Ojima, A